The NEWHEART projects develop a new treatment option after heart attacks / ERC funding of 150,000 euros over 18 months allows researchers to explore the commercial or societal potential of their work ...
New review reveals how non-genomic estrogen signaling undermines treatment response and fuels tumor progression Hormone receptor–positive breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results